FY2023 · ended Dec 31, 2023 · Revenue $0 · Filed Apr 5, 2024
HST Global, Inc. (HSTC) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2023, which ended Dec 31, 2023, it reported revenue of $0 and a net loss of $146,210.
Revenue (TTM)
$0
Net income (TTM)
$-101,508
+30.0% vs year-ago TTM
Operating cash flow (TTM)
$-38,193
-90.8% vs year-ago TTM
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
5.25M
+0.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HSTC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Virginia Beach, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 797564
- Former names
- NT HOLDING CORP. (until Mar 31, 2009); ABSS CORP (until Aug 12, 2004); UNICO INC (until May 22, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
FY 2020 Dec 31, 2020 |
FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$140,907 | -$141,035 | -$145,718 | -$207,978 | -$151,554 |
| Net income | -$146,210 | -$145,074 | -$148,360 | -$208,992 | $426,572 |
| Operating cash flow | -$20,906 | -$21,035 | -$29,836 | -$26,971 | -$91,905 |
| Total assets | $1,526 | $190 | $225 | $660 | $1,955 |
| Total liabilities | $593,593 | $446,047 | $301,008 | $153,083 | $5,385 |
| Stockholders' equity | -$592,067 | -$445,857 | -$300,783 | -$152,423 | -$3,430 |
| Cash and investments | $1,526 | $190 | $225 | $660 | $1,955 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Nov 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 20, 2025 | Mar 13, 2025 |
| 10-Q | Quarterly report | Nov 22, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 12, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 26, 2024 | Sep 25, 2024 |
| 10-Q | Quarterly report | Aug 26, 2024 | Jun 30, 2024 |
All 329 HST Global, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.